Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

1.

Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.

Naito Y, Hosokawa M, Hao H, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Hirota S, Ohyanagi M, Tsujino T, Masuyama T.

Biochem Biophys Res Commun. 2013 Jun 28;436(2):145-51. doi: 10.1016/j.bbrc.2013.05.059. Epub 2013 May 23.

PMID:
23707944
2.

Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.

Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1606-16. doi: 10.1152/ajpheart.00590.2009. Epub 2009 Sep 25.

3.

Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats.

Umar S, Nadadur RD, Li J, Maltese F, Partownavid P, van der Laarse A, Eghbali M.

Hypertension. 2011 Sep;58(3):512-8. doi: 10.1161/HYPERTENSIONAHA.110.168781. Epub 2011 Jul 11.

4.

Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.

Hessel MH, Steendijk P, den Adel B, Schutte CI, van der Laarse A.

Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2424-30. Epub 2006 May 26.

5.

2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.

Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.

Vascul Pharmacol. 2006 Dec;45(6):358-67. Epub 2006 Jun 8.

PMID:
16872912
6.

Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.

Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.

Respir Res. 2014 Nov 25;15:148. doi: 10.1186/s12931-014-0148-4. Erratum in: Respir Res. 2016 Nov 4;17 (1):142.

7.

Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.

Tofovic SP, Salah EM, Mady HH, Jackson EK, Melhem MF.

J Cardiovasc Pharmacol. 2005 Oct;46(4):430-7.

PMID:
16160593
8.

PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.

Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F.

J Pharmacol Exp Ther. 2010 Aug;334(2):364-72. doi: 10.1124/jpet.109.165001. Epub 2010 Apr 29.

9.

Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension.

Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R Jr, Baptista MJ, Lourenço AP, Oliveira SM, Brandão-Nogueira A, Teles A, Fortunato JM, Leite-Moreira AF.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2885-90. Epub 2004 Aug 26.

10.

Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels.

Hessel M, Steendijk P, den Adel B, Schutte C, van der Laarse A.

Cell Physiol Biochem. 2009;24(3-4):201-10. doi: 10.1159/000233246. Epub 2009 Aug 3.

11.

Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.

Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.

Eur J Pharmacol. 2009 Jul 1;614(1-3):70-6. doi: 10.1016/j.ejphar.2009.04.016. Epub 2009 Apr 17.

PMID:
19379725
12.

Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension.

Tanaka Y, Takase B, Yao T, Ishihara M.

Am J Respir Cell Mol Biol. 2013 Sep;49(3):426-36. doi: 10.1165/rcmb.2012-0089OC.

PMID:
23600532
13.

Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?

Balestra GM, Mik EG, Eerbeek O, Specht PA, van der Laarse WJ, Zuurbier CJ.

Respir Res. 2015 Feb 3;16:6. doi: 10.1186/s12931-015-0178-6.

14.

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.

Dahal BK, Kosanovic D, Kaulen C, Cornitescu T, Savai R, Hoffmann J, Reiss I, Ghofrani HA, Weissmann N, Kuebler WM, Seeger W, Grimminger F, Schermuly RT.

Respir Res. 2011 May 2;12:60. doi: 10.1186/1465-9921-12-60.

15.

Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.

Liu B, Wang XQ, Yu L, Zhou TF, Wang XM, Liu HM.

Exp Lung Res. 2009 Jun;35(5):411-26.

16.

Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.

Xie YP, Chen B, Sanders P, Guo A, Li Y, Zimmerman K, Wang LC, Weiss RM, Grumbach IM, Anderson ME, Song LS.

Hypertension. 2012 Feb;59(2):355-62. doi: 10.1161/HYPERTENSIONAHA.111.180968. Epub 2011 Dec 27.

17.

Distinct loading conditions reveal various patterns of right ventricular adaptation.

Borgdorff MA, Bartelds B, Dickinson MG, Steendijk P, de Vroomen M, Berger RM.

Am J Physiol Heart Circ Physiol. 2013 Aug 1;305(3):H354-64. doi: 10.1152/ajpheart.00180.2013. Epub 2013 May 31.

18.

Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.

Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, Francis J, Nair A, Unger T, Raizada MK, Steckelings UM, Sumners C, Katovich MJ.

Br J Pharmacol. 2015 May;172(9):2219-31. doi: 10.1111/bph.13044. Epub 2015 Feb 27.

19.

Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.

Gur S, Kadowitz PJ, Thammasitboon S, Lasky JA, Hellstrom WJ.

J Androl. 2009 Sep-Oct;30(5):495-504. doi: 10.2164/jandrol.108.006700. Epub 2009 Feb 5.

20.

Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.

Rocchetti M, Sala L, Rizzetto R, Staszewsky LI, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A.

Cardiovasc Res. 2014 Oct 1;104(1):37-48. doi: 10.1093/cvr/cvu188. Epub 2014 Aug 18.

PMID:
25139747

Supplemental Content

Support Center